Manulife Finl Stock Price, News & Analysis

Manulife Financial (MFC) has announced the results of its conversion privilege for Non-cumulative Rate Reset Class 1 Shares Series 19. With only 3,700 Series 19 Preferred Shares elected for conversion, falling below the minimum requirement of one million shares, holders cannot convert their Series 19 shares into Series 20 Preferred Shares.

After March 19, 2025, Series 19 shareholders will receive fixed rate non-cumulative preferential cash dividends quarterly, subject to Board declaration. The dividend rate for March 20, 2025 to March 19, 2030 will be 5.16900% annually, or $0.323063 per share quarterly, calculated as the five-year Government of Canada bond yield plus 2.30%.

Manulife maintains the option to redeem Series 19 Preferred Shares, wholly or partially, on March 19, 2030, and every five years thereafter, subject to specific conditions.

Manulife (MFC) has issued a warning to investors regarding an unsolicited mini-tender offer from Ocehan to purchase up to 50,000 Manulife common shares (less than 0.003% of outstanding shares) at $34.20 per share. The company emphasizes this offer represents a significant discount of approximately 20% below current market prices on both TSX and NYSE as of February 24, 2025.

The mini-tender offer, designed to acquire less than 5% of company shares, bypasses standard disclosure and procedural requirements under Canadian and U.S. securities regulations. Both the Canadian Securities Administrators (CSA) and U.S. Securities and Exchange Commission (SEC) have expressed concerns about such offers, particularly regarding investors potentially accepting without understanding the below-market pricing.

Manulife Financial (TSX/NYSE/PSE: MFC) has announced the implementation of an automatic share repurchase plan as part of its previously announced normal course issuer bid (NCIB). Under this plan, Manulife's designated broker will be able to repurchase common shares automatically, including during periods when the company would typically be inactive in the market due to internal trading blackout periods or insider trading rules.

The plan, which has received TSX pre-clearance, allows for share repurchases whose timing, volume, and price will be determined by market conditions. The company notes that actual repurchase activities will depend on various factors, including earnings, cash requirements, financial condition, market conditions, capital requirements under LICAT standards, and applicable regulations.

Manulife (TSX/NYSE/PSE: MFC) has announced two strategic appointments to its Board of Directors, effective February 28, 2025. Nancy Carroll, a former partner at McCarthy Tétrault LLP with over 40 years of insurance and financial services legal expertise, and John Montalbano, a former CEO of RBC Global Asset Management and current Principal of Tower Beach Capital , will join the board.

Carroll brings extensive experience in regulatory, M&A, compliance, and governance matters in the insurance sector. She will serve on the Audit Committee and Corporate Governance and Nominating Committee. Montalbano, with his wealth and asset management background, will join the Management Resources and Compensation Committee and Risk Committee.

Manulife Financial (TSX/NYSE/PSE: MFC, SEHK: 945) has announced the filing of its 2024 audited annual financial statements and related Management Discussion and Analysis (MD&A) for the year ended December 31, 2024. The documents have been filed with both the Canadian Securities Administrators and the U.S. Securities and Exchange Commission on Form 40-F.

The financial information is accessible on Manulife's website in the investors section. Shareholders can request physical copies of these documents at no cost through the company's website.

Manulife Financial (TSX/NYSE/PSE: MFC) has announced its quarterly preferred share dividends for multiple share classes. The dividends will be paid on or after March 19, 2025 to shareholders of record as of March 5, 2025.

The dividend payments vary by share class, ranging from $0.14675 to $0.396875 per share. The announcement covers eleven different preferred share series, including Class A Shares Series 2 and 3, and Class 1 Shares Series 3, 4, 9, 11, 13, 15, 17, 19, and 25.

Manulife (MFC) has announced a significant increase in its quarterly dividend for common shareholders. The Board of Directors approved a 10.0% increase, raising the dividend by 4 cents to $0.44 per share. The dividend will be payable on March 19, 2025, to shareholders of record as of March 5, 2025.

Regarding the company's Canadian and U.S. Dividend Reinvestment and Share Purchase Plans, Manulife will purchase common shares on the open market for dividend reinvestment and optional cash purchases. The purchase price will be based on the average actual cost without any applicable discounts.

Manulife Financial (MFC) has announced a new Normal Course Issuer Bid (NCIB) program to repurchase and cancel up to 51.5 million common shares, representing approximately 3% of its issued and outstanding shares. The program will run from February 24, 2025, to February 23, 2026.

The company can purchase up to 1,420,093 shares daily on the TSX, representing 25% of the average daily trading volume. Purchases will be made through TSX, NYSE, and alternative trading systems at prevailing market prices. Under its previous 2024 NCIB program, Manulife has already repurchased 88,466,133 shares at an average price of $39.11 per share.

The NCIB provides Manulife flexibility in its capital management strategy, balancing regulatory capital ratios with shareholder value generation. The company may also undertake repurchases outside North America and enter into derivative-based programs, subject to regulatory approval.

Manulife Financial (MFC) reported strong full year and fourth quarter results for 2024, with record core earnings of $7.2 billion, up 8% from 2023, and $1.9 billion in Q4, up 6% year-over-year. Net income attributed to shareholders reached $5.4 billion in 2024, a $0.3 billion increase from 2023.

The company achieved significant growth across key metrics, including core EPS of $3.87 (up 11%) and core ROE of 16.4%. Insurance new business results showed remarkable growth with 30%+ increases in APE sales, new business CSM, and NBV. Global WAM generated $13.3 billion in net inflows.

Notable developments include a 10% increase in quarterly dividend per common share and the announcement of a new NCIB program to repurchase up to 3% of outstanding common shares. The company also completed significant reinsurance transactions, including two LTC blocks, demonstrating progress in portfolio transformation.